Article
Mutation K42R in ribosomal protein S12 does not affect susceptibility of Mycobacterium smegmatis 16S rRNA A-site mutants to 2-deoxystreptamines.
PloS one - 5 Aug 2010
Kalapala Sarath K, Hobbie Sven N, Böttger Erik C, Shcherbakov Dmitry
Abstract excerpt
Recent studies have suggested that ribosomal protein S12 modulates 16S rRNA function and susceptibility to 2-deoxystreptamine aminoglycosides. To study whether the non-restrictive K42R mutation in RpsL affects 2-deoxystreptamine susceptibility in Mycobacterium smegmatis, we studied the drug susceptibility pattern of various mutants with genetic alterations in the 16S rRNA decoding A-site in the context of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
